Neosil Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.7M
- Investors
-
1
Neosil General Information
Description
Developer of dermatology-focused specialty pharmaceutical products. The company has developed core topical anti-infective technology which provides broad anti-microbial activity, long duration of activity and formulation flexibility.
Contact Information
Website
www.neosil.comCorporate Office
- 5980 Horton Street
- Suite 525
- Emeryville, CA 94608
- United States
Corporate Office
- 5980 Horton Street
- Suite 525
- Emeryville, CA 94608
- United States
Neosil Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 20-Oct-2008 | $6.7M | Completed | Product Development | ||
| 2. Mezzanine | 15-May-2007 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 18-Oct-2006 | $32.1M | $32.1M | Completed | Product Development |
Neosil Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Neosil Patents
Neosil Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050249818-A1 | Polycationic antimicrobial therapeutic | Inactive | 03-May-2004 | ||
| WO-2005115417-A2 | Polycationic antimicrobial therapeutic | Inactive | 03-May-2004 | ||
| WO-2005115417-A3 | Polycationic antimicrobial therapeutic | Inactive | 03-May-2004 | A61K31/785 |
Neosil Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Burrill & Co | Merchant Banking Firm | Minority | ||
| MPM BioImpact | Venture Capital | Minority | ||
| Shalon Ventures | Venture Capital | Minority |
Neosil FAQs
-
When was Neosil founded?
Neosil was founded in 2003.
-
Where is Neosil headquartered?
Neosil is headquartered in Emeryville, CA.
-
What industry is Neosil in?
Neosil’s primary industry is Pharmaceuticals.
-
Is Neosil a private or public company?
Neosil is a Private company.
-
What is the current valuation of Neosil?
The current valuation of Neosil is .
-
What is Neosil’s current revenue?
The current revenue for Neosil is .
-
How much funding has Neosil raised over time?
Neosil has raised $34.2M.
-
Who are Neosil’s investors?
Burrill & Co, MPM BioImpact, and Shalon Ventures have invested in Neosil.
-
When was Neosil acquired?
Neosil was acquired on 20-Oct-2008.
-
Who acquired Neosil?
Neosil was acquired by Peplin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process